AI Summary
This study details the development of a peptide inhibitor targeting the extraterminal domain in BRD4, which has been found to effectively suppress breast cancer both in laboratory studies (in vitro) and in animal models (in vivo). This research could potentially lead to new therapeutic strategies for treating breast cancer by targeting specific protein domains.